No insider purchase over the last 90 days. The latest was filed 18 Jan 2021.
Every trade that managers of PolarCool AB disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 2 filings came from 2 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
With 2 filings in twelve months, the company is quieter than the median of 7 filings across the 890 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 1 purchase and no sales.
There has been no open-market purchase by an insider of PolarCool AB for at least a year.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
3 of 3 declarations
PolarCool AB is a company focused on developing innovative solutions for the treatment of sports injuries. It is listed on the Stockholm Stock Exchange (XSTO).
Purchases our model currently ranks for the recommendations list.
All recommendations